MRI Contrast Safety Exam Practice
Questions and Correct Answers
(Verified Answers) Plus Rationales 2027
Q&A | Instant Download Pdf
1. What is the primary purpose of a gadolinium-based contrast agent (GBCA)
during MRI?
A. To increase ionizing radiation exposure
B. To improve visualization of certain tissues and vascular structures
C. To eliminate the need for MRI sequences
D. To reduce the patient's heart rate
Correct Answer: B
Rationale: Gadolinium-based contrast agents are used to alter MRI signal
characteristics and improve visualization of selected tissues, lesions, and vascular
structures. They do not produce ionizing radiation.
2. Which element is responsible for the paramagnetic properties of most
conventional MRI contrast agents?
A. Calcium
B. Iodine
C. Gadolinium
D. Sodium
Correct Answer: C
Rationale: Gadolinium is a paramagnetic metal ion that alters local magnetic
properties and produces the desired MRI contrast effect. In clinical GBCAs,
gadolinium is administered in a chelated form.
,3. Why is gadolinium administered as a chelated compound in clinical MRI?
A. To make it radioactive
B. To bind the gadolinium ion and reduce its biological toxicity
C. To increase its ionizing radiation output
D. To prevent it from affecting MRI signal
Correct Answer: B
Rationale: Free gadolinium ions are toxic. Chelation binds gadolinium within a
larger molecular structure, allowing it to be used clinically while reducing the
toxicity associated with free gadolinium.
4. Which type of contrast agent is most commonly associated with contrast-
enhanced MRI?
A. Gadolinium-based contrast agent
B. Barium sulfate
C. Iodinated oral contrast
D. Carbon dioxide
Correct Answer: A
Rationale: Gadolinium-based contrast agents are the principal class of intravenous
contrast agents used for contrast-enhanced MRI.
5. Which patient factor is particularly important when assessing the risk of
nephrogenic systemic fibrosis (NSF)?
A. Hair color
B. Severe renal dysfunction
C. Mild seasonal allergies
D. Visual acuity
Correct Answer: B
,Rationale: Severe renal dysfunction is a major consideration in NSF risk
assessment because impaired renal clearance can increase exposure to
gadolinium-based contrast agents. Current ACR guidance differentiates GBCAs by
their NSF risk characteristics.
6. Which group of patients generally requires particular attention to renal
function before administration of certain GBCAs?
A. Patients with significant kidney impairment
B. Patients with normal renal function
C. Patients with corrected vision
D. Patients with seasonal rhinitis
Correct Answer: A
Rationale: Kidney function affects the clearance of many GBCAs. Patients with
significant renal impairment require appropriate assessment and selection of
contrast agent based on current safety guidance.
7. What is nephrogenic systemic fibrosis (NSF)?
A. An acute allergic reaction to MRI
B. A rare systemic fibrosing disorder associated with certain GBCA exposures,
particularly in high-risk patients
C. A type of MRI artifact
D. A bacterial infection caused by contrast injection
Correct Answer: B
Rationale: NSF is a rare systemic disorder historically associated with exposure to
certain gadolinium-based contrast agents in patients with severe renal
dysfunction. Modern GBCA selection has substantially reduced the risk.
8. Which statement best describes the current approach to GBCA-associated
NSF risk?
, A. All GBCAs have identical NSF risk
B. NSF risk varies among GBCA groups and patient circumstances
C. NSF occurs routinely after every GBCA administration
D. NSF is unrelated to renal function
Correct Answer: B
Rationale: Current ACR guidance recognizes differences among GBCA groups with
respect to NSF risk. The 2025 ACR update specifically clarified GBCA group
classification for NSF considerations.
9. What is the most appropriate general approach when a patient has severe
renal impairment and contrast-enhanced MRI is being considered?
A. Ignore renal status because GBCAs never require renal consideration
B. Evaluate the clinical need and select an appropriate GBCA strategy according to
current guidance
C. Automatically administer the highest available dose
D. Substitute iodinated contrast without considering the examination
Correct Answer: B
Rationale: Severe renal impairment requires careful consideration of the
indication, GBCA selection, and current institutional and professional guidance.
The decision should balance diagnostic benefit and patient safety.
10. Which type of acute contrast reaction is characterized by symptoms such as
nausea, warmth, or transient flushing without an allergic-like mechanism?
A. Physiologic reaction
B. NSF
C. Extravasation
D. Delayed tissue necrosis
Correct Answer: A
Rationale: Physiologic reactions result from the pharmacologic or physiologic
effects of contrast media rather than an allergic-like mechanism. The ACR
Questions and Correct Answers
(Verified Answers) Plus Rationales 2027
Q&A | Instant Download Pdf
1. What is the primary purpose of a gadolinium-based contrast agent (GBCA)
during MRI?
A. To increase ionizing radiation exposure
B. To improve visualization of certain tissues and vascular structures
C. To eliminate the need for MRI sequences
D. To reduce the patient's heart rate
Correct Answer: B
Rationale: Gadolinium-based contrast agents are used to alter MRI signal
characteristics and improve visualization of selected tissues, lesions, and vascular
structures. They do not produce ionizing radiation.
2. Which element is responsible for the paramagnetic properties of most
conventional MRI contrast agents?
A. Calcium
B. Iodine
C. Gadolinium
D. Sodium
Correct Answer: C
Rationale: Gadolinium is a paramagnetic metal ion that alters local magnetic
properties and produces the desired MRI contrast effect. In clinical GBCAs,
gadolinium is administered in a chelated form.
,3. Why is gadolinium administered as a chelated compound in clinical MRI?
A. To make it radioactive
B. To bind the gadolinium ion and reduce its biological toxicity
C. To increase its ionizing radiation output
D. To prevent it from affecting MRI signal
Correct Answer: B
Rationale: Free gadolinium ions are toxic. Chelation binds gadolinium within a
larger molecular structure, allowing it to be used clinically while reducing the
toxicity associated with free gadolinium.
4. Which type of contrast agent is most commonly associated with contrast-
enhanced MRI?
A. Gadolinium-based contrast agent
B. Barium sulfate
C. Iodinated oral contrast
D. Carbon dioxide
Correct Answer: A
Rationale: Gadolinium-based contrast agents are the principal class of intravenous
contrast agents used for contrast-enhanced MRI.
5. Which patient factor is particularly important when assessing the risk of
nephrogenic systemic fibrosis (NSF)?
A. Hair color
B. Severe renal dysfunction
C. Mild seasonal allergies
D. Visual acuity
Correct Answer: B
,Rationale: Severe renal dysfunction is a major consideration in NSF risk
assessment because impaired renal clearance can increase exposure to
gadolinium-based contrast agents. Current ACR guidance differentiates GBCAs by
their NSF risk characteristics.
6. Which group of patients generally requires particular attention to renal
function before administration of certain GBCAs?
A. Patients with significant kidney impairment
B. Patients with normal renal function
C. Patients with corrected vision
D. Patients with seasonal rhinitis
Correct Answer: A
Rationale: Kidney function affects the clearance of many GBCAs. Patients with
significant renal impairment require appropriate assessment and selection of
contrast agent based on current safety guidance.
7. What is nephrogenic systemic fibrosis (NSF)?
A. An acute allergic reaction to MRI
B. A rare systemic fibrosing disorder associated with certain GBCA exposures,
particularly in high-risk patients
C. A type of MRI artifact
D. A bacterial infection caused by contrast injection
Correct Answer: B
Rationale: NSF is a rare systemic disorder historically associated with exposure to
certain gadolinium-based contrast agents in patients with severe renal
dysfunction. Modern GBCA selection has substantially reduced the risk.
8. Which statement best describes the current approach to GBCA-associated
NSF risk?
, A. All GBCAs have identical NSF risk
B. NSF risk varies among GBCA groups and patient circumstances
C. NSF occurs routinely after every GBCA administration
D. NSF is unrelated to renal function
Correct Answer: B
Rationale: Current ACR guidance recognizes differences among GBCA groups with
respect to NSF risk. The 2025 ACR update specifically clarified GBCA group
classification for NSF considerations.
9. What is the most appropriate general approach when a patient has severe
renal impairment and contrast-enhanced MRI is being considered?
A. Ignore renal status because GBCAs never require renal consideration
B. Evaluate the clinical need and select an appropriate GBCA strategy according to
current guidance
C. Automatically administer the highest available dose
D. Substitute iodinated contrast without considering the examination
Correct Answer: B
Rationale: Severe renal impairment requires careful consideration of the
indication, GBCA selection, and current institutional and professional guidance.
The decision should balance diagnostic benefit and patient safety.
10. Which type of acute contrast reaction is characterized by symptoms such as
nausea, warmth, or transient flushing without an allergic-like mechanism?
A. Physiologic reaction
B. NSF
C. Extravasation
D. Delayed tissue necrosis
Correct Answer: A
Rationale: Physiologic reactions result from the pharmacologic or physiologic
effects of contrast media rather than an allergic-like mechanism. The ACR
